Clinical Trials
Study Title:
67Cu SARTATE Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High Risk Neuroblastoma: A Multi center, Dose escalation, Open label, Non randomized, Phase 1 2a Theranostic Clinical Trial
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu. Study Coordinator, Hannah Kinder, at kinderh@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |